Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Oncolytics initiates US Phase II lung cancer trial
This trial is a single arm, two-stage, open-label, Phase II study of Reolysin given intravenously with paclitaxel and carboplatin every three weeks. Patients will receive four to six
This trial is a single arm, two-stage, open-label, Phase II study of Reolysin given intravenously with paclitaxel and carboplatin every three weeks. Patients will receive four to six
The financing will take Calabar’s product through a Phase II study with repeated dosing. The active drug, physostigmine, a cholinesterase inhibitor, targets the minor salivary glands with a
The patients will be treated with OX914 in a disease model for inflammatory airway disease. Approximately 36 patients with seasonal allergic rhinitis will be given placebo or OX914
Symbion CP Holdings (Symbion Consumer) manufactures, markets and distributes nutraceuticals and over the counter brands throughout Australia and New Zealand. It is reported that Symbion Consumer has a
Taxotere is already approved in Japan for the treatment of breast cancer, non-small cell lung, gastric, head and neck, ovarian, esophageal and endometrial cancers. This new approval is
Surface Imaging Systems (SIS) will be renamed Bruker Nano and will operate under its previous management. Frank Burgaezy, executive vice president of Bruker AXS, said: “The new Bruker
The overall results demonstrated no statistically significant differences between percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) in rates of death or myocardial infarction (MI). The
Under the terms of the merger agreement, Novacea will issue new shares of its common stock to Transcept stockholders based on an exchange ratio to be determined prior
The claims data will be aggregated and analyzed from a web-based suite of management reports and workflow tools that the therapist will use alongside any existing practice management
The Pacsgear European office will provide sales and logistics functions in support of the company’s products, which connect medical image management and electronic health record systems. The company